TipRanks
GC Biopharma Corp. (KR:006280)
:006280
South Korea Market
006280
GC Biopharma Corp.
RESEARCH TOOLSreports

GC Biopharma Corp. (006280) Ratios

― Followers

GC Biopharma Corp. Ratios

KR:006280's free cash flow for Q2 2026 was ₩0.26. For the 2026 fiscal year, KR:006280's free cash flow was decreased by ₩ and operating cash flow was ₩<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.35 1.20 1.56 1.20 1.81
Quick Ratio
 0.47 0.42 0.59 0.60 0.99
Cash Ratio
 0.04 0.04 0.03 0.06 0.19
Solvency Ratio
 0.02 0.05 0.04 0.04 0.14
Operating Cash Flow Ratio
 0.18 0.09 -0.07 >-0.01 0.22
Short-Term Operating Cash Flow Coverage
 0.34 0.16 -0.14 -0.01 0.64
Net Current Asset Value
₩ -133.06B₩ -206.43B₩ -61.03B₩ -64.30B₩ 21.54B
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.33 0.30 0.27 0.23
Debt-to-Equity Ratio
 0.76 0.81 0.66 0.56 0.43
Debt-to-Capital Ratio
 0.43 0.45 0.40 0.36 0.30
Long-Term Debt-to-Capital Ratio
 0.20 0.17 0.21 0.06 0.17
Financial Leverage Ratio
 2.28 2.44 2.19 2.03 1.90
Debt Service Coverage Ratio
 0.23 0.24 0.19 0.21 0.83
Interest Coverage Ratio
 0.92 1.35 0.79 1.21 4.42
Debt to Market Cap
 0.59 0.48 0.35 0.42 0.32
Interest Debt Per Share
 153.98K 90.45K 76.10K 65.93K 52.04K
Net Debt to EBITDA
 6.35 6.00 10.02 6.14 2.51
Profitability Margins
Gross Profit Margin
25.25%26.92%28.69%29.79%34.00%
EBIT Margin
2.82%3.41%-0.04%2.08%7.14%
EBITDA Margin
7.19%7.81%4.78%6.75%10.93%
Operating Profit Margin
2.39%3.41%1.91%2.12%4.75%
Pretax Profit Margin
-2.96%-1.77%-2.45%-1.67%5.01%
Net Profit Margin
-2.54%-0.23%-1.56%-1.64%3.82%
Continuous Operations Profit Margin
-3.23%-1.49%-2.54%-1.22%4.06%
Net Income Per EBT
85.77%13.23%63.93%98.15%76.35%
EBT Per EBIT
-123.84%-52.10%-128.04%-78.80%105.49%
Return on Assets (ROA)
-1.77%-0.16%-0.96%-1.01%2.59%
Return on Equity (ROE)
-4.01%-0.38%-2.10%-2.05%4.93%
Return on Capital Employed (ROCE)
2.60%3.71%1.63%1.94%4.09%
Return on Invested Capital (ROIC)
2.01%2.33%1.36%1.09%3.01%
Return on Tangible Assets
-2.01%-0.18%-1.08%-1.10%2.96%
Earnings Yield
-6.17%-0.26%-1.28%-1.85%4.52%
Efficiency Ratios
Receivables Turnover
 5.40 4.86 4.12 3.72 4.13
Payables Turnover
 8.28 8.21 7.64 7.94 9.31
Inventory Turnover
 1.66 1.63 1.60 2.21 2.55
Fixed Asset Turnover
 2.22 2.07 1.83 1.71 1.84
Asset Turnover
 0.70 0.67 0.61 0.62 0.68
Working Capital Turnover Ratio
 6.47 6.06 5.58 5.33 3.48
Cash Conversion Cycle
 244.07 254.26 268.32 217.08 192.18
Days of Sales Outstanding
 67.64 75.10 88.62 98.05 88.41
Days of Inventory Outstanding
 220.49 223.62 227.47 165.00 142.96
Days of Payables Outstanding
 44.06 44.46 47.78 45.97 39.19
Operating Cycle
 288.13 298.72 316.10 263.05 231.37
Cash Flow Ratios
Operating Cash Flow Per Share
 28.67K 8.71K -4.68K -479.52 10.44K
Free Cash Flow Per Share
 11.30K 2.37K -8.40K -11.52K 2.14K
CapEx Per Share
 17.37K 6.34K 3.71K 11.04K 8.30K
Free Cash Flow to Operating Cash Flow
 0.39 0.27 1.79 24.02 0.21
Dividend Paid and CapEx Coverage Ratio
 1.40 1.09 -0.86 -0.04 1.00
Capital Expenditure Coverage Ratio
 1.65 1.37 -1.26 -0.04 1.26
Operating Cash Flow Coverage Ratio
 0.20 0.10 -0.06 >-0.01 0.21
Operating Cash Flow to Sales Ratio
 0.09 0.05 -0.03 >-0.01 0.07
Free Cash Flow Yield
5.06%1.49%-4.68%-9.16%1.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -28.77 -388.27 -77.95 -53.91 22.14
Price-to-Sales (P/S) Ratio
 0.73 0.91 1.22 0.88 0.85
Price-to-Book (P/B) Ratio
 0.65 1.49 1.64 1.10 1.09
Price-to-Free Cash Flow (P/FCF) Ratio
 19.77 66.97 -21.37 -10.92 59.25
Price-to-Operating Cash Flow Ratio
 4.39 18.25 -38.32 -262.34 12.16
Price-to-Earnings Growth (PEG) Ratio
 0.26 4.72 59.06 0.38 -0.47
Price-to-Fair Value
 0.65 1.49 1.64 1.10 1.09
Enterprise Value Multiple
 16.51 17.67 35.52 19.22 10.26
Enterprise Value
 2.33T 2.75T 2.85T 2.11T 1.92T
EV to EBITDA
 16.51 17.67 35.52 19.22 10.26
EV to Sales
 1.19 1.38 1.70 1.30 1.12
EV to Free Cash Flow
 32.12 101.38 -29.78 -16.05 78.47
EV to Operating Cash Flow
 12.66 27.62 -53.39 -385.56 16.11
Tangible Book Value Per Share
 154.72K 92.60K 102.83K 114.89K 109.97K
Shareholders’ Equity Per Share
 192.39K 106.67K 109.76K 113.93K 116.37K
Tax and Other Ratios
Effective Tax Rate
 -0.09 0.16 -0.04 0.27 0.19
Revenue Per Share
 305.53K 174.46K 147.19K 142.53K 149.94K
Net Income Per Share
 -7.76K -409.48 -2.30K -2.33K 5.73K
Tax Burden
 0.86 0.13 0.64 0.98 0.76
Interest Burden
 -1.05 -0.52 61.31 -0.80 0.70
Research & Development to Revenue
 0.06 0.08 0.10 0.11 0.11
SG&A to Revenue
 0.08 0.08 0.08 0.08 0.10
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -3.86 -21.28 1.25 0.21 1.72
Currency in KRW